Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy AloneSteven N. Seyedin, John M. Watkins, Darrion Mitchell et al.|Pathology & Oncology Research|2017Cited by 9
Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning AnalysisJohn M. Watkins, John M. Buatti, Darrion Mitchell et al.|Clinical Genitourinary Cancer|2016Cited by 4
The impact of prostate cancer (PC) margin extent (ME) at radical prostatectomy (RP) on biochemical relapse-free survival (bRFS).Steven N. Seyedin, John M. Watkins, Sarah L. Mott et al.|Journal of Clinical Oncology|2018Cited by 2
A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation TherapySteven N. Seyedin, Joseph M. Caster, John M. Watkins et al.|Advances in Radiation Oncology|2021Cited by 2
Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancerJohn M. Watkins, John M. Buatti, Bryan G. Allen et al.|Reports of Practical Oncology & Radiotherapy|2020Cited by 1